Compare Veritone Inc (VERI) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Veritone Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Veritone Inc trades at $1.13 (market cap $97.60M), while State Street SPDR S&P Biotech ETF trades at $154.5. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals.
| VERI | XBI | |
|---|---|---|
Market Cap | $97.60M | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $8.39 | $164.28 |
52-Week Low | $1.02 | $85.16 |
Enterprise Value | $129.63M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Veritone Inc
Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
